Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
AAPS PharmSciTech
| AAPS PharmSciTech |
| Pubbl/distr/stampa | Arlington, VA, : American Association of Pharmaceutical Scientists, ©2000- |
| Disciplina | 615 |
| Soggetto topico |
Drugs - Dosage forms
Biopharmaceutics Drug Design Dosage Forms Drug Evaluation Pharmaceutical Preparations |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. Zeitschrift |
| Soggetto non controllato | Pharmacy, Therapeutics, & Pharmacology |
| ISSN | 1530-9932 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
American Association of Pharmaceutical Scientists PharmSciTech
PharmSciTech |
| Record Nr. | UNISA-996200658003316 |
| Arlington, VA, : American Association of Pharmaceutical Scientists, ©2000- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
AAPS PharmSciTech
| AAPS PharmSciTech |
| Pubbl/distr/stampa | Arlington, VA, : American Association of Pharmaceutical Scientists, ©2000- |
| Disciplina | 615 |
| Soggetto topico |
Drugs - Dosage forms
Biopharmaceutics Drug Design Dosage Forms Drug Evaluation Pharmaceutical Preparations Farmacocinètica Química farmacèutica Disseny de medicaments Formes farmacèutiques |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. Zeitschrift Revistes electròniques. |
| ISSN | 1530-9932 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
American Association of Pharmaceutical Scientists PharmSciTech
PharmSciTech |
| Record Nr. | UNINA-9910146958203321 |
| Arlington, VA, : American Association of Pharmaceutical Scientists, ©2000- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Combination products in therapy
| Combination products in therapy |
| Pubbl/distr/stampa | [London] : , : Springer Healthcare, , [2011-2014] |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Therapeutics
Combined modality therapy Drugs - Dosage forms Drug Compounding |
| Soggetto genere / forma | Periodicals. |
| Soggetto non controllato | Pharmacy, Therapeutics, & Pharmacology |
| ISSN | 2190-9180 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996208180403316 |
| [London] : , : Springer Healthcare, , [2011-2014] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Combination products in therapy
| Combination products in therapy |
| Pubbl/distr/stampa | [London] : , : Springer Healthcare, , [2011-2014] |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Therapeutics
Combined modality therapy Drugs - Dosage forms Drug Compounding Terapèutica Posologia |
| Soggetto genere / forma |
Periodical
Periodicals. Revistes electròniques. |
| ISSN | 2190-9180 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910141614903321 |
| [London] : , : Springer Healthcare, , [2011-2014] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Compounding sterile preparations [[electronic resource] /] / [edited by] E. Clyde Buchanan, Philip J. Schneider
| Compounding sterile preparations [[electronic resource] /] / [edited by] E. Clyde Buchanan, Philip J. Schneider |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Bethesda, Md., : American Society of Health-System Pharmacists, c2009 |
| Descrizione fisica | 1 online resource (495 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
BuchananE. Clyde
SchneiderPhilip J |
| Soggetto topico |
Sterilization
Pharmaceutical technology Drugs - Dosage forms |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-4619-3809-0
1-58528-330-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | section 1. Sterile preparation -- section 2. Quality management -- section 3. Appendixes. |
| Record Nr. | UNINA-9910464248703321 |
| Bethesda, Md., : American Society of Health-System Pharmacists, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Design and manufacture of pharmaceutical tablets / / Reynir Eyjolfsson
| Design and manufacture of pharmaceutical tablets / / Reynir Eyjolfsson |
| Autore | Eyjolfsson Reynir |
| Pubbl/distr/stampa | London, England : , : AP, , 2015 |
| Descrizione fisica | 1 online resource (68 p.) |
| Disciplina | 615.1 |
| Soggetto topico |
Drugs - Dosage forms
Pharmaceutical industry Tablets (Medicine) |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-12-802187-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title Page; Copyright Page; Dedication; Contents; Preface; Abbreviations; Chapter One - Introduction; 1.1 - General considerations; 1.2 - Particle sizes; 1.3 - Excipients; 1.3.1 - Ac-Di-Sol SD-711; 1.3.2 - Aerosil 200; 1.3.3 - Avicel PH-102; 1.3.4 - Compactrol; 1.3.5 - Corn starch; 1.3.6 - Di-Tab; 1.3.7 - Eudragit RS PO; 1.3.8 - Magnesium stearate 5712; 1.3.9 - Mannitol 60; 1.3.10 - Methocel K4M Premium; 1.3.11 - Methocel K100M Premium; 1.3.12 - Methocel K100LV Premium; 1.3.13 - Pharmatose 150M; 1.3.14 - Polyplasdone XL-10; 1.3.15 - Povidone; 1.3.16 - Primojel; 1.3.17 - Pruv
1.3.18 - Sodium bicarbonate1.3.19 - Starch 1500; 1.3.20 - Stearic acid 2236; 1.3.21 - Sterotex K; 1.3.22 - Tablettose 80; 1.3.23 - Talc; 1.4 - Equipment; 1.5 - Mixing of pharmaceutical powders; 1.6 - Design of experiments; 1.6.1 - Introduction to statistical design of experiments - the two-level factorial; 1.6.1.1 - Introduction; 1.6.1.2 - Designed experiments; 1.6.1.3 - Basic considerations; 1.6.1.4 - Two-level factorials; 1.6.1.5 - Two-level fractional factorials; 1.6.2 - Response surface methodology (RSM); 1.6.2.1 - Introduction; 1.6.2.2 - RSM and a sieving process variable study 1.6.2.3 - RSM investigation of the properties of a three-component tablet formulationReferences; Chapter two - Conventional-Release (CR) Tablets; 2.1 - Low-dose tablet by direct compression (DC); 2.1.1 - Properties of active pharmaceutical ingredient (API); 2.1.2 - Design; 2.1.3 - Manufacturing method; 2.1.4 - Remarks; 2.2 - High-dose tablet by direct compression; 2.2.1 - Properties of active pharmaceutical ingredient; 2.2.2 - Design; 2.2.3 - Manufacturing method; 2.2.4 - Remarks; 2.3 - Low-solubility API, low-dose tablet by wet granulation (WG) 2.3.1 - Properties of active pharmaceutical ingredient2.3.2 - Design; 2.3.3 - Manufacturing method; 2.3.4 - Remarks; 2.4 - Soluble API, low-dose tablet by wet granulation; 2.4.1 - Properties of active pharmaceutical ingredient; 2.4.2 - Design; 2.4.3 - Manufacturing method; 2.4.4 - Remarks; 2.5 - Low-solubility API, high-dose tablet by wet granulation; 2.5.1 - Properties of active pharmaceutical ingredient; 2.5.2 - Design; 2.5.3 - Manufacturing method; 2.5.4 - Remarks; 2.6 - Soluble API, high-dose tablet by wet granulation; 2.6.1 - Properties of active pharmaceutical ingredient; 2.6.2 - Design 2.6.3 - Manufacturing method2.6.4 - Remarks; References; Chapter three - Slow-Release (SR) Tablets; 3.1 - Slow-release tablet using a lipophilic release control agent; 3.1.1 - Properties of active pharmaceutical ingredient (API); 3.1.2 - Design; 3.1.3 - Manufacturing method; 3.1.4 - Remarks; 3.2 - Slow-release tablet using Eudragit and Methocel as release control agents; 3.2.1 - Properties of active pharmaceutical ingredient; 3.2.2 - Design; 3.2.3 - Manufacturing method; 3.2.4 - Remarks; 3.3 - Slow-release tablet using a mixture of Methocels as release control agent 3.3.1 - Properties of active pharmaceutical ingredient |
| Record Nr. | UNINA-9910459964503321 |
Eyjolfsson Reynir
|
||
| London, England : , : AP, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Design and manufacture of pharmaceutical tablets / / Reynir Eyjolfsson
| Design and manufacture of pharmaceutical tablets / / Reynir Eyjolfsson |
| Autore | Eyjolfsson Reynir |
| Pubbl/distr/stampa | London, England : , : AP, , 2015 |
| Descrizione fisica | 1 online resource (68 p.) |
| Disciplina | 615.1 |
| Soggetto topico |
Drugs - Dosage forms
Pharmaceutical industry Tablets (Medicine) |
| ISBN | 0-12-802187-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title Page; Copyright Page; Dedication; Contents; Preface; Abbreviations; Chapter One - Introduction; 1.1 - General considerations; 1.2 - Particle sizes; 1.3 - Excipients; 1.3.1 - Ac-Di-Sol SD-711; 1.3.2 - Aerosil 200; 1.3.3 - Avicel PH-102; 1.3.4 - Compactrol; 1.3.5 - Corn starch; 1.3.6 - Di-Tab; 1.3.7 - Eudragit RS PO; 1.3.8 - Magnesium stearate 5712; 1.3.9 - Mannitol 60; 1.3.10 - Methocel K4M Premium; 1.3.11 - Methocel K100M Premium; 1.3.12 - Methocel K100LV Premium; 1.3.13 - Pharmatose 150M; 1.3.14 - Polyplasdone XL-10; 1.3.15 - Povidone; 1.3.16 - Primojel; 1.3.17 - Pruv
1.3.18 - Sodium bicarbonate1.3.19 - Starch 1500; 1.3.20 - Stearic acid 2236; 1.3.21 - Sterotex K; 1.3.22 - Tablettose 80; 1.3.23 - Talc; 1.4 - Equipment; 1.5 - Mixing of pharmaceutical powders; 1.6 - Design of experiments; 1.6.1 - Introduction to statistical design of experiments - the two-level factorial; 1.6.1.1 - Introduction; 1.6.1.2 - Designed experiments; 1.6.1.3 - Basic considerations; 1.6.1.4 - Two-level factorials; 1.6.1.5 - Two-level fractional factorials; 1.6.2 - Response surface methodology (RSM); 1.6.2.1 - Introduction; 1.6.2.2 - RSM and a sieving process variable study 1.6.2.3 - RSM investigation of the properties of a three-component tablet formulationReferences; Chapter two - Conventional-Release (CR) Tablets; 2.1 - Low-dose tablet by direct compression (DC); 2.1.1 - Properties of active pharmaceutical ingredient (API); 2.1.2 - Design; 2.1.3 - Manufacturing method; 2.1.4 - Remarks; 2.2 - High-dose tablet by direct compression; 2.2.1 - Properties of active pharmaceutical ingredient; 2.2.2 - Design; 2.2.3 - Manufacturing method; 2.2.4 - Remarks; 2.3 - Low-solubility API, low-dose tablet by wet granulation (WG) 2.3.1 - Properties of active pharmaceutical ingredient2.3.2 - Design; 2.3.3 - Manufacturing method; 2.3.4 - Remarks; 2.4 - Soluble API, low-dose tablet by wet granulation; 2.4.1 - Properties of active pharmaceutical ingredient; 2.4.2 - Design; 2.4.3 - Manufacturing method; 2.4.4 - Remarks; 2.5 - Low-solubility API, high-dose tablet by wet granulation; 2.5.1 - Properties of active pharmaceutical ingredient; 2.5.2 - Design; 2.5.3 - Manufacturing method; 2.5.4 - Remarks; 2.6 - Soluble API, high-dose tablet by wet granulation; 2.6.1 - Properties of active pharmaceutical ingredient; 2.6.2 - Design 2.6.3 - Manufacturing method2.6.4 - Remarks; References; Chapter three - Slow-Release (SR) Tablets; 3.1 - Slow-release tablet using a lipophilic release control agent; 3.1.1 - Properties of active pharmaceutical ingredient (API); 3.1.2 - Design; 3.1.3 - Manufacturing method; 3.1.4 - Remarks; 3.2 - Slow-release tablet using Eudragit and Methocel as release control agents; 3.2.1 - Properties of active pharmaceutical ingredient; 3.2.2 - Design; 3.2.3 - Manufacturing method; 3.2.4 - Remarks; 3.3 - Slow-release tablet using a mixture of Methocels as release control agent 3.3.1 - Properties of active pharmaceutical ingredient |
| Record Nr. | UNINA-9910787164003321 |
|
Eyjolfsson Reynir
|
||
| London, England : , : AP, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Design and manufacture of pharmaceutical tablets / / Reynir Eyjolfsson
| Design and manufacture of pharmaceutical tablets / / Reynir Eyjolfsson |
| Autore | Eyjolfsson Reynir |
| Pubbl/distr/stampa | London, England : , : AP, , 2015 |
| Descrizione fisica | 1 online resource (68 p.) |
| Disciplina | 615.1 |
| Soggetto topico |
Drugs - Dosage forms
Pharmaceutical industry Tablets (Medicine) |
| ISBN | 0-12-802187-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title Page; Copyright Page; Dedication; Contents; Preface; Abbreviations; Chapter One - Introduction; 1.1 - General considerations; 1.2 - Particle sizes; 1.3 - Excipients; 1.3.1 - Ac-Di-Sol SD-711; 1.3.2 - Aerosil 200; 1.3.3 - Avicel PH-102; 1.3.4 - Compactrol; 1.3.5 - Corn starch; 1.3.6 - Di-Tab; 1.3.7 - Eudragit RS PO; 1.3.8 - Magnesium stearate 5712; 1.3.9 - Mannitol 60; 1.3.10 - Methocel K4M Premium; 1.3.11 - Methocel K100M Premium; 1.3.12 - Methocel K100LV Premium; 1.3.13 - Pharmatose 150M; 1.3.14 - Polyplasdone XL-10; 1.3.15 - Povidone; 1.3.16 - Primojel; 1.3.17 - Pruv
1.3.18 - Sodium bicarbonate1.3.19 - Starch 1500; 1.3.20 - Stearic acid 2236; 1.3.21 - Sterotex K; 1.3.22 - Tablettose 80; 1.3.23 - Talc; 1.4 - Equipment; 1.5 - Mixing of pharmaceutical powders; 1.6 - Design of experiments; 1.6.1 - Introduction to statistical design of experiments - the two-level factorial; 1.6.1.1 - Introduction; 1.6.1.2 - Designed experiments; 1.6.1.3 - Basic considerations; 1.6.1.4 - Two-level factorials; 1.6.1.5 - Two-level fractional factorials; 1.6.2 - Response surface methodology (RSM); 1.6.2.1 - Introduction; 1.6.2.2 - RSM and a sieving process variable study 1.6.2.3 - RSM investigation of the properties of a three-component tablet formulationReferences; Chapter two - Conventional-Release (CR) Tablets; 2.1 - Low-dose tablet by direct compression (DC); 2.1.1 - Properties of active pharmaceutical ingredient (API); 2.1.2 - Design; 2.1.3 - Manufacturing method; 2.1.4 - Remarks; 2.2 - High-dose tablet by direct compression; 2.2.1 - Properties of active pharmaceutical ingredient; 2.2.2 - Design; 2.2.3 - Manufacturing method; 2.2.4 - Remarks; 2.3 - Low-solubility API, low-dose tablet by wet granulation (WG) 2.3.1 - Properties of active pharmaceutical ingredient2.3.2 - Design; 2.3.3 - Manufacturing method; 2.3.4 - Remarks; 2.4 - Soluble API, low-dose tablet by wet granulation; 2.4.1 - Properties of active pharmaceutical ingredient; 2.4.2 - Design; 2.4.3 - Manufacturing method; 2.4.4 - Remarks; 2.5 - Low-solubility API, high-dose tablet by wet granulation; 2.5.1 - Properties of active pharmaceutical ingredient; 2.5.2 - Design; 2.5.3 - Manufacturing method; 2.5.4 - Remarks; 2.6 - Soluble API, high-dose tablet by wet granulation; 2.6.1 - Properties of active pharmaceutical ingredient; 2.6.2 - Design 2.6.3 - Manufacturing method2.6.4 - Remarks; References; Chapter three - Slow-Release (SR) Tablets; 3.1 - Slow-release tablet using a lipophilic release control agent; 3.1.1 - Properties of active pharmaceutical ingredient (API); 3.1.2 - Design; 3.1.3 - Manufacturing method; 3.1.4 - Remarks; 3.2 - Slow-release tablet using Eudragit and Methocel as release control agents; 3.2.1 - Properties of active pharmaceutical ingredient; 3.2.2 - Design; 3.2.3 - Manufacturing method; 3.2.4 - Remarks; 3.3 - Slow-release tablet using a mixture of Methocels as release control agent 3.3.1 - Properties of active pharmaceutical ingredient |
| Record Nr. | UNINA-9910817344203321 |
|
Eyjolfsson Reynir
|
||
| London, England : , : AP, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dictionary of pharmaceutical dosage forms / / Jeffrey T. Solate
| Dictionary of pharmaceutical dosage forms / / Jeffrey T. Solate |
| Autore | Solate Jeffrey T. |
| Pubbl/distr/stampa | Boca Raton : , : CRC Press, , 2020 |
| Descrizione fisica | 1 online resource (169 pages) |
| Disciplina | 615.19003 |
| Soggetto topico | Drugs - Dosage forms |
| ISBN |
1-315-15944-9
1-351-65956-1 1-351-65957-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910794495903321 |
|
Solate Jeffrey T.
|
||
| Boca Raton : , : CRC Press, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dictionary of pharmaceutical dosage forms / / Jeffrey T. Solate
| Dictionary of pharmaceutical dosage forms / / Jeffrey T. Solate |
| Autore | Solate Jeffrey T. |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boca Raton : , : CRC Press, , 2020 |
| Descrizione fisica | 1 online resource (169 pages) |
| Disciplina | 615.19003 |
| Soggetto topico | Drugs - Dosage forms |
| ISBN |
1-315-15944-9
1-351-65956-1 1-351-65957-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Introduction -- Pills -- Fluoxetine (Prozac) -- Birth Control Pills -- Tablets -- Benadryl -- Tablets -- Codeine -- Capsules -- Doxycycline -- Lithium Citrate -- Thin Film -- Listerine PocketPacks -- Cordran® Tape -- Syrup (Liquid Solution or Suspension) -- Celestone® (Betamethasone) Syrup -- Clemastine Fumarate Syrup -- Midazolam Hydrochloride Syrup -- Powder, Liquid, or Solid Crystals -- Examples -- Natural or Herbal Plant, Seed, or Food -- Rosemary -- Aerosol -- Flovent (Fluticasone Propionate) -- Inhaler -- Advair Diskus -- Entocort (Budesonide) -- Aerobid (Flunisolide) -- Albuterol Sulfate -- Nebulizer -- Intal Nebulizer Solution -- NebuPent (Pentamidine Isethionate) -- Natural Herb -- Lobelia -- Natural Herb -- Cayenne Pepper (Capsicum) -- Freebase Powder -- Viokase -- Vaporizer -- Eucalyptus -- Intradermal (ID) Injection -- Tuberculin Skin Testing (Mantoux Test) -- Intramuscular (IM) Injection -- Bicillin C-R Tubex -- Intraosseous (IR) Injection -- Examples -- Intraperitoneal (IP) Injection -- Chemotherapy Drugs to Treat Some Cancers -- Intravenous (IV) Injection -- Loxilan -- Subcutaneous or Hypodermic Injection -- Insulin -- Ear Drops -- Polysporin Eye and Ear Drops -- Eye Drops -- Artificial Tears -- Ophthacare -- Nasal Spray -- Mouth Spray -- Zolpimist -- Douches -- Cream -- Amcinonide Cream -- Gel -- Diclofenac Gel -- Liniment -- Examples -- Ointment -- Examples -- Lotion -- Calamine -- Paste -- Examples -- Skin Patch -- Nicotine Patch -- Pain Relief Patch -- Rectal Suppository -- Examples -- Vaginal Suppository -- Cleocin® Vaginal Ovules -- Mycelex-G (Clotrimazole Vaginal) -- Urethral Suppository -- Alprostadil -- Liquid Suppository -- Laxative -- Bibliography -- Index. |
| Record Nr. | UNINA-9910955241403321 |
|
Solate Jeffrey T.
|
||
| Boca Raton : , : CRC Press, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
